ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kosei Yasumoto
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakahashi, H.
Right arrow Articles by Sugimachi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakahashi, H.
Right arrow Articles by Sugimachi, K.

Ann Thorac Surg 1988;46:178-181
© 1988 The Society of Thoracic Surgeons

Articles

Results of Surgical Treatment of Patients with T3 Non—Small Cell Lung Cancer

Hisashi Nakahashi, M.D., Kosei Yasumoto, M.D.*, Teruyoshi Ishida, M.D., Akira Nagashima, M.D., Toyohiko Nishino, M.D., Takeshi Oka, M.D., Keizo Sugimachi, M.D.

From the Second Department of Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan

Accepted for publication January 22, 1988.

* Address reprint requests to Dr. Yasumoto, The Second Department of Surgery, Faculty of Medicine, Kyushu University, Maedashi 3–1–1, Higashi-ku, Fukuoka 812, Japan.

Sixty-one patients with T3 non-small cell lung cancer were surgically treated in our department from February, 1974, through April, 1986. The overall 5-year survival, excluding patients with pleurisy, was 23%, and the 5-year survival for patients undergoing complete resection and incomplete resection was 42% and 10%, respectively (p < 0.01). Survival in patients with T3 N0 and T3 N1 or N2 disease was 33% and 0 at 5 years, respectively. The prognosis for patients with pleurisy was poor, and all died within 3 years.

Therefore, complete lung resection should be done in patients with T3 N0 non-small cell lung cancer if complete resection is expected. Long-term survival is less likely for patients with lymph node metastases if complete resection cannot be performed.




This article has been cited by other articles:


Home page
 ChestHome page
W. J. Scott, J. Howington, and B. Movsas
Treatment of Stage II Non-small Cell Lung Cancer
Chest, January 1, 2003; 123(2009): 188S - 201S.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Kameyama, C.-l. Huang, D. Liu, T. Okamoto, E. Hayashi, Y. Yamamoto, and H. Yokomise
Problems related to TNM staging: Patients with stage III non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 503 - 510.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Sawabata, A. Matsumura, A. Motohiro, Y. Osaka, K. Gennga, S. Fukai, and T. Mori
Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis?
Ann. Thorac. Surg., February 1, 2002; 73(2): 412 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Deslauriers
Current surgical treatment of nonsmall cell lung cancer 2001
Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Riquet, L. Lang-Lazdunski, F. Le Pimpec-Barthes, A. Dujon, R. Souilamas, C. Danel, and D. Manac'h
Characteristics and prognosis of resected T3 non-small cell lung cancer
Ann. Thorac. Surg., January 1, 2002; 73(1): 253 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka
How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancer
Ann. Thorac. Surg., December 1, 1999; 68(6): 2049 - 2052.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. van Velzen, A. Brutel de la Riviere, H. J.J. Elbers, J.-W. J. Lammers, and J. M.M. van den Bosch
Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma
Ann. Thorac. Surg., April 1, 1999; 67(4): 903 - 907.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. C. M. Pitz, A. B. de la Riviere, H. R. J. Elbers, C. J. J. Westermann, and J. M. van den Bosch
Results of Resection of T3 Non-Small Cell Lung Cancer Invading the Mediastinum or Main Bronchus
Ann. Thorac. Surg., October 1, 1996; 62(4): 1016 - 1020.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
Results of Surgical Treatment of Patients with T3 Non-Small Cell Lung Cancer
Ann. Thorac. Surg., January 1, 1996; 61(1): 273 - 274.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
D. E. Van Raemdonck, A. Schneider, and R. J. Ginsberg
Surgical treatment for higher stage non-small cell lung cancer
Ann. Thorac. Surg., November 1, 1992; 54(5): 999 - 1013.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. W. Shields
The "incomplete" resection
Ann. Thorac. Surg., April 1, 1989; 47(4): 487 - 488.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The Society of Thoracic Surgeons.